[14C] and [13C] labellings from N-(2-diethylaminoethyl)-4-iodobenzamide, and N-(3-deimethylaminopropyl)-4-iodobenzamide, melanoma tracers
N-(2-diethylaminoethyl)-4-iodobenzamide (I) and N-(3-dimethylaminopropyl)-4-iodobenzamide (II), recently developed in our laboratory, are promising agents for metastatic melanoma detection in nuclear medicine. In order to study their 'in vivo' metabolism,
Moreau,Parry,Bayle,Papon,Labarre,Veyre
p. 805 - 813
(2007/10/02)
More Articles about upstream products of 170745-63-8